Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 75, Issue 3, 2012, Pages 7-9

  Vaizova, O E ^a   Zautner, N A ^a   Alifirova, V M ^a   Vengerovskil, A I ^a  

^a SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Acute ischemic stroke; Choline alfoscerate; Citicoline; Neuron specific enolase; S100 protein

Indexed keywords

BIOLOGICAL MARKER; CHOLINE; CHOLINE ALFOSCERATE; CITICOLINE; NEUROPROTECTIVE AGENT; PROTEIN S 100; ENOLASE; GLYCEROPHOSPHORYLCHOLINE; NOOTROPIC AGENT;

ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NEUROPROTECTION; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; STROKE;

BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CYTIDINE DIPHOSPHATE CHOLINE; GLYCERYLPHOSPHORYLCHOLINE; HUMANS; NOOTROPIC AGENTS; PHOSPHOPYRUVATE HYDRATASE; S100 PROTEINS; STROKE;

EID: 84863791643     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Consilium medicum, 5(5), 3-5 (2003).
2. H. D. Abraha, R. G. Buttenvoiih, R. A. Sherwood, Ann. Clin. Biochem., 34(4), 366-370 (1997).
3. R. M. Adibhatla, J. F. Hatcher, R. J. Dempsey, Stroke, 32(12), 2376 2381 (2001).
4. J. Alvarez-Sabin, G. C. Roman, Stroke, 42, S40-S43 (2011).
5. W. M. Clark, B. J. Williams, K. A. Selzer, et al., Stroke, 30(13), 2592-2597(1999).
6. Guidelines for management of ischemic stroke and transient ischemic attack, Cerebrovas. Dis, 25(3), 457-507 (2008).
7. P. Dassan, G. Keir, M.M. Brown, Cerebrovasc Dis, 27(3), 295-302 (2009).
8. A. Dávalos, J. Castillo, J. Álvarez-Sabín, et al., Stroke, 33(14), 2850-2857 (2002).
9. P. Martens, A. Raabe, P. Johnsson, Stroke, 29(12), 2363-2366 (1998).
10. T. Oshitari, N. Yoshida-Hata, S. Yamamoto, Brain Res, 1346(30), 43-51 (2010).